Factorial Energy GC reports initial FAC holdings
Factorial Energy Inc. General Counsel Jason A. Duva filed an initial Form 3 reporting his equity holdings in the company.
Rhea-AI Filing Summary
Factorial Energy Inc. General Counsel Jason A. Duva filed an initial Form 3 reporting his equity holdings in the company. He directly holds 44,681 shares of Series A Common Stock as of the reported date.
Duva also reports several stock option awards to acquire Series A Common Stock, including options for 295,446 shares at an exercise price of $2.6400 per share expiring on October 7, 2035, and options for 366,840 shares at $0.8800 per share expiring on May 8, 2032. Footnotes indicate that some options are already fully vested and exercisable, while others vest over time subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Duva Jason A
Role
General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Series A Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,088,770 contracts (Direct);
Series A Common Stock — 44,681 shares (Direct)
Footnotes (3)
- F1. The shares underlying this option are fully vested and exercisable.
- F2. 25% of the shares underlying this option vested on August 25, 2023, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- F3. 25% of the shares underlying this option shall vest on September 22, 2026, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
Direct common shares: 44,681 shares
Option grant 1 exercise price: $2.6400/share
Option grant 1 underlying shares: 295,446 shares
+4 more
7 metrics
Direct common shares
44,681 shares
Series A Common Stock held directly as of Form 3
Option grant 1 exercise price
$2.6400/share
Stock Option (Right to Buy), expiration October 7, 2035
Option grant 1 underlying shares
295,446 shares
Underlying Series A Common Stock at $2.6400 exercise price
Option grant 2 exercise price
$0.8800/share
Stock Option (Right to Buy), expiration May 8, 2032
Option grant 2 underlying shares
366,840 shares
Underlying Series A Common Stock at $0.8800 exercise price
Option grant 3 underlying shares
168,104 shares
Stock option at $0.8800, expiration March 12, 2035
Smaller option grant underlying shares
15,260 shares
Stock option at $2.6400, expiration October 7, 2035
Key Terms
Form 3, Series A Common Stock, Stock Option (Right to Buy), exercise price, +1 more
5 terms
Form 3 regulatory
"General Counsel Jason A. Duva filed an initial Form 3 reporting his equity holdings"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Series A Common Stock financial
"He directly holds 44,681 shares of Series A Common Stock as of the reported date"
Series A common stock is a specific class of a company’s ordinary shares issued during an early formal funding round, carrying the ownership rights and voting power tied to that class. For investors it signals an early-stage equity claim with potential upside if the business grows, but also greater risk and typically less liquidity than shares in mature, publicly traded firms—imagine buying a seat on a startup’s team before the company has proven itself.
Stock Option (Right to Buy) financial
"Duva also reports several stock option awards to acquire Series A Common Stock"
exercise price financial
"including options for 295,446 shares at an exercise price of $2.6400 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vested financial
"Footnotes indicate that some options are already fully vested and exercisable"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Jason Duva’s Form 3 filing show for Factorial Energy (FAC)?
The Form 3 shows General Counsel Jason A. Duva’s existing equity stake in Factorial Energy. He holds 44,681 shares of Series A Common Stock plus multiple stock options with exercise prices of $2.6400 and $0.8800 per share, expiring between 2032 and 2035.
What stock options does Jason Duva report in his Factorial Energy (FAC) Form 3?
Jason Duva reports several stock options to buy Series A Common Stock, including 295,446 underlying shares at $2.6400 per share and 366,840 underlying shares at $0.8800 per share. These options have expiration dates between 2032 and 2035 and are held directly.
Are Jason Duva’s Factorial Energy (FAC) options already vested?
Some options are fully vested while others vest over time. One footnote states certain option shares are fully vested and exercisable. Other grants vest 25% on specified 2023 and 2026 dates, with the remaining shares vesting in 36 monthly installments, contingent on continued service.
What are the exercise prices on Jason Duva’s Factorial Energy (FAC) options?
Jason Duva’s reported options have exercise prices of $2.6400 and $0.8800 per share. Each option covers Series A Common Stock, with different grants tied to specific expiration dates in 2032, 2035, and vesting schedules described in the accompanying footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
